OCA IR 0.1 mg, 0,1 mg and 1,5 mg Placebo tablets, OCA 1.5 mg
747-308
Phase 3 small_molecule active
Quick answer
OCA IR 0.1 mg, 0,1 mg and 1,5 mg Placebo tablets, OCA 1.5 mg for Biliary Atresia, Post-hepatoportoenterostomy is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Biliary Atresia, Post-hepatoportoenterostomy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active